[1]杨闯,张永川,古广强,等.利胆排石汤联合纤维十二指肠镜治疗胆总管结石40例临床观察[J].西部中医药,2013,26(08):40-42.
　YANG Chuang,ZHANG Yongchuan,GU Guangqiang,et al.Clinical Observation on LiDan PaiShiTang and Duodenofiberscope in Treating 40 Cases of Choledocholithiasis[J].Western Journal of Traditional Chinese Medicine,2013,26(08):40-42.
点击复制

利胆排石汤联合纤维十二指肠镜治疗胆总管结石40例临床观察
分享到：

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
26
期数:
2013年08期
页码:
40-42
栏目:
出版日期:
2013-08-15

文章信息/Info

Title:
Clinical Observation on LiDan PaiShiTang and Duodenofiberscope in Treating 40 Cases of Choledocholithiasis
文章编号:
1004-6852(2013)08-0040-03
作者:
杨闯，张永川，古广强，李华国
绵阳市第三人民医院，四川 绵阳 621000
Author(s):
YANG Chuang, ZHANG Yongchuan, GU Guangqiang, LI Huaguo
Mianyang Municipal the Third People′s Hospital, Mianyang 621000, China
关键词:
胆总管结石; 纤维十二指肠镜; 利胆排石汤
Keywords:
choledocholithiasis;  duodenofiberscope;  LiDan PaiShi Tang
分类号:
R657
文献标志码:
A
摘要:
目的：观察利胆排石汤联合纤维十二指肠镜治疗胆总管结石的临床疗效。方法：将80例胆总管结石患者随机分为观察组、对照组各40例。对照组给予纤维十二指肠镜治疗，观察组在对照组治疗的基础上给予利胆排石汤治疗，手术前后1周内每日1剂，水煎服。观察两组患者发热、黄疸、腹痛等临床症状积分改善情况及治疗前和治疗后3个月时天冬氨酸氨基转移酶(AST)、丙氨酸氨基转移酶(ALT)、淀粉酶(AMY)、总胆红素(TBIL)水平。结果：黄疸、发热、恶心呕吐、腹痛等症状积分治疗后观察组分别为(0.75±0.12)、(2.33±0.22)、(2.57±0.24)、(0.54±0.26)分，对照组分别为(1.57±0.22)、(1.43±0.37)、(1.47±0.24)、(1.74±0.26)分，2组均较治疗前明显好转(P＜0.05)，且观察组优于对照组(P＜0.05)。TBIL、AMY、ALT、AST等指标治疗后观察组分别为(12.54±2.25)μmol/L，(48.43±18.87)、(33.54±6.42)、(33.34±4.25)U/L，对照组分别为(19.75±6.25)μmol/L，(84.53±13.57)、(34.71±6.24)、(33.94±5.16)U/L，2组均较治疗前明显好转(P＜0.05)，且观察组优于对照组(P＜0.05)。结论：利胆排石汤联合纤维十二指肠镜治疗胆总管结石可改善患者临床症状及血清TBIL、AMY、ALT、AST水平。
Abstract:
Objective: To observe curative effects of duodenofiberscope and LiDan PaiShiTang in the treatment for choledocholithiasis. Method: Eighty patients were randomized into the observation group and the control group. The control group received duodenofiberscope and the observation group took LiDan PaiShi Tang, one dose per day in one week before and after surgery, water decocted. The levels of total bilirubin (TBiL), amylase (AMY), alanine aminotransferase (ALT), aspartate aminotransferase (AST) were observed before treating and in three months after treating as well as the improvements of clinical symptoms scale including fever, jaundice, abdominal pain and others. Result: Symptom scales of jaundice, fever, nausea and vomiting, abdominal pain after treating were (0.75±0.12),(2.33±0.22),( 2.57±0.24) and (0.54±0.26) in the observation group, (1.57±0.22), (1.43±0.37), (1.47±0.24) and (1.74±0.26) in the control group, both groups were improved greatly than before treating (P＜0.05), the improvement of the observation group was superior to that of the control group (P＜0.05). The indexes of TBiL, AMY, ALT and AST in the observation group were (12.54±2.25)μmol/L, (48.43±18.87) U/L,(33.54±6.42) U/L and (33.34±4.25) U/L, which of the control group were (19.75±6.25)μmol/L, (84.53±13.57) U/L, (34.71±6.24) U/L and (33.94±5.16) U/L, both groups were improved remarkably than before treating in both groups(P＜0.05), the observation group was superior to the control group (P＜0.05). Conclusion: Duodenofiberscope and LiDan PaiShi Tang in treating choledocholithiasis could improve clinical symptom and the levels of the indexes in the serum which include TBiL, AMY, ALT and AST.

相似文献/References:

[1]李璐璐,黄晓俊△,肖吉元,等.两种剂量排石汤治疗胆总管结石ERCP术后患者的临床研究[J].西部中医药,2019,32(02):101.
　LI Lulu,HUANG Xiaojun,XIAO Jiyuan,et al.Clinical Study on Two Different Dosages of Modified PaiShi Decoction or Choledocholith Patients after ERCP[J].Western Journal of Traditional Chinese Medicine,2019,32(08):101.
[2]吕震,唐乾利,卓臣义,等.大黄灵仙方对腹腔镜胆总管切开取石疗效的影响[J].西部中医药,2023,36(05):90.[doi:10.12174/j.issn.2096-9600.2023.05.20]
　LYU Zhen,TANG Qianli,ZHUO Chenyi,et al.Influence of Dahuang Lingxian Prescription on Clinical Effects of Laparoscopic Choledochotomy Lithotomy[J].Western Journal of Traditional Chinese Medicine,2023,36(08):90.[doi:10.12174/j.issn.2096-9600.2023.05.20]

备注/Memo

备注/Memo:
收稿日期：2013-02-21 作者简介：杨闯(1973—)，男，博士学位，副主任医师。研究方向：肝脏肿瘤及胆道结石疾病的中西医结合诊治。
更新日期/Last Update: 2013-08-15